- Home
- MASI vs MEDP Comparison
MASI vs MEDP Comparison
Compare MASI & MEDP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MASI
- MEDP
- Stock Information
- Founded
- MASI 1989
- MEDP 1992
- Country
- MASI United States
- MEDP United States
- Employees
- MASI N/A
- MEDP N/A
- Industry
- MASI Medical/Dental Instruments
- MEDP Biotechnology: Commercial Physical & Biological Resarch
- Sector
- MASI Health Care
- MEDP Health Care
- Exchange
- MASI Nasdaq
- MEDP Nasdaq
- Market Cap
- MASI 8.8B
- MEDP 10.5B
- IPO Year
- MASI 2007
- MEDP 2016
- Fundamental
- Price
- MASI $177.76
- MEDP $350.40
- Analyst Decision
- MASI Buy
- MEDP Buy
- Analyst Count
- MASI 7
- MEDP 10
- Target Price
- MASI $179.67
- MEDP $389.89
- AVG Volume (30 Days)
- MASI 505.3K
- MEDP 207.9K
- Earning Date
- MASI 02-25-2025
- MEDP 02-10-2025
- Dividend Yield
- MASI N/A
- MEDP N/A
- EPS Growth
- MASI N/A
- MEDP 33.84
- EPS
- MASI 1.45
- MEDP 11.42
- Revenue
- MASI $2,042,600,000.00
- MEDP $2,070,866,000.00
- Revenue This Year
- MASI $3.90
- MEDP $13.95
- Revenue Next Year
- MASI $2.21
- MEDP $5.68
- P/E Ratio
- MASI $121.32
- MEDP $30.38
- Revenue Growth
- MASI N/A
- MEDP 16.24
- 52 Week Low
- MASI $101.61
- MEDP $293.37
- 52 Week High
- MASI $183.14
- MEDP $459.77
- Technical
- Relative Strength Index (RSI)
- MASI 54.84
- MEDP 52.52
- Support Level
- MASI $171.04
- MEDP $341.83
- Resistance Level
- MASI $183.14
- MEDP $351.86
- Average True Range (ATR)
- MASI 5.19
- MEDP 8.28
- MACD
- MASI 0.30
- MEDP 0.14
- Stochastic Oscillator
- MASI 59.61
- MEDP 56.90
About MASI Masimo Corporation
Masimo Corp is a global technology company. The company's segment includes healthcare and non-healthcare. The healthcare business segment is a key revenue driver, develops, manufactures, and markets a variety of noninvasive patient monitoring technologies, hospital automation and connectivity solutions, remote monitoring devices and consumer health products. Its non-healthcare segment includes consumer audio business develops, manufactures, markets sells and licenses premium and luxury audio sound products and related integration technologies.
About MEDP Medpace Holdings Inc.
Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical-device firms. It also offers ancillary services such as bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has over 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati and its operations are principally based in the us, but it also operates in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.